Your browser doesn't support javascript.
loading
Optimal Irreversible Electroporation Combined with Nano-Enabled Immunomodulatory to Boost Systemic Antitumor Immunity.
Peng, Wencheng; Cao, Yanbing; Zhang, Yuting; Zhong, Aoxue; Zhang, Cao; Wei, Zuwu; Liu, Xiaolong; Dong, Shoulong; Wu, Jingcheng; Xue, Yanan; Wu, Ming; Yao, Chenguo.
Afiliación
  • Peng W; State Key Laboratory of Power Transmission Equipment & System Security and New Technology, Chongqing University, Chongqing, 400044, P. R. China.
  • Cao Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Zhang Y; Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, P. R. China.
  • Zhong A; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Zhang C; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Wei Z; Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, P. R. China.
  • Liu X; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Dong S; Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, P. R. China.
  • Wu J; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Xue Y; The United Innovation of Mengchao Hepatobiliary Technology Key Laboratory of Fujian Province, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, 350025, P. R. China.
  • Wu M; Mengchao Med-X Center, Fuzhou University, Fuzhou, 350116, P. R. China.
  • Yao C; State Key Laboratory of Power Transmission Equipment & System Security and New Technology, Chongqing University, Chongqing, 400044, P. R. China.
Adv Healthc Mater ; 13(7): e2302549, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38059737
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Límite: Humans Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Receptor de Muerte Celular Programada 1 / Neoplasias Límite: Humans Idioma: En Revista: Adv Healthc Mater Año: 2024 Tipo del documento: Article